Programme

	Thursday 29 January - Day one
11.45am	Registration, lunch, exhibition and poster viewing
12.30pm	Welcome and introduction Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery
12.50pm	Session 1: Novel imaging in SRS Chairs: Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery SP1 - Could rCBV Values Prior to SRS be Used to Predict Progression Status of Brain Metastases? Heather Rowe, Clinical Scientist, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust Beyond Conventional MRI: Advanced Imaging in Post-SRS Treatment Response Assessment Dr Markand Patel, Consultant Neuroradiologist, Imperial College Healthcare NHS Trust SP2 - Evaluating early changes in the post-radiosurgery vestibular schwannoma microenvironment: a multinuclear MRI study Daniel Lewis, ST6 Neurosurgical Trainee, North-West Deanery, NIHR Clinical Lecturer, University of Manchester Optimal imaging for planning AVMs Dr George Tse, Consultant Interventional Neuroradiologist, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Discussion
1.50pm	Session 2: Single session versus hypofractionation for benign targets Chairs: Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Dr Rovel Colaco, Consultant Clinical Oncologist, The Christie NHS Foundation Trust SP3 - Cyberknife radiosurgery and hypofractionated stereotactic radiotherapy for larger vestibular schwannomas Dr Amy Irwin, Clinical Oncology ST6, University Hospitals Birmingham SP4 - Radiological and Clinical Outcomes in Benign Meningiomas: A Comparison of Single-Fraction versus Multi-Fraction Radiosurgery Dr Natasha Chaudhury, Clinical Oncology Registrar, The Royal Marsden Hospital NHS Foundation Trust SP5 - Outcomes using Cyberknife Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Meningiomas Dr James Riley, Clinical Oncology Registrar, Queen Elizabeth Hospital Birmingham Hypofractionation for benign tumours Dr Paul Sanghera, Consultant Clinical Oncologist, University Hospitals Birmingham
2.40pm	Session 3: Sponsored Presentations (I) Chair: Ian Paddick, Consultant Physicist, Medical Physics Limited Leksell Gamma Knife treatment statistics Per Nylund, Chairman Leksell Gamma Knife Society, Elekta The power of AI for auto-contouring of brain metastases David James, Sr. Marketing Manager Radiosurgery, Siemens Healthineers International AG
3.00pm	Refreshments, exhibition and poster viewing
3.30pm	Session 4: Use of PTVs and managing uncertainty in SRS Chairs: Dr James Powell, Consultant, Velindre University NHS Trust, and Dr Abdul Hussein Mroué, Lead SRS Physicist, GenesisCare Keynote: The Case for margins in SRS Professor Marcel Van Herk, Chair in Radiotherapy Physics, Group Leader Adaptive Radiotherapy, The University of Manchester, The Christie NHS Foundation Trust The case against margins in SRS Ian Paddick, Consultant Physicist, Medical Physics Limited Discussion
4.10pm	Session 5: Approaches and outcomes from SRS for brain metastases: Case reports Chairs: Dr Jennifer King, Consultant Clinical Oncologist, The Christie NHS Foundation Trust, and Dr Claire Barker, Consultant Clinical Oncologist, The Christie NHS Foundation Trust SP6 - Multi-arc non-coplanar VMAT - can extracranial dose be reduced without compromising plan quality Esmé Votta, Radiotherapy Physicist, Barts Health NHS Trust SP7 - Investigating the optimal prescription isodose for linac-based SRS Dan Welsh, Higher Principal Clinical Scientist, The Christie NHS Foundation Trust SP8 - One isocenter to treat them all: a 10 year retrospective study of SRS for Multiple Brain Metastases Dr Paola Zuccoli, Radiation Oncologist, Ecomedica-Ergéa Group SP9 - CyberKnife Stereotactic Radiosurgery for Brainstem Metastases Mitchell Hickman, Consultant Radiographer, Queen Elizabeth Hospital Birmingham
4.55pm	Session 6: AVMs Chairs: Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery, and Greg Fellows, Consultant Neurosurgeon, Bristol Royal Hospital for Children SP10 - Stereotactic Radiosurgery for Persistent Paediatric AVMs: The Relevance of Previous Treatment Response on the Decision for Further Treatment, National Centre for Stereotactic Radiosurgery in Sheffield, UK David Eagle, Post-CCT Fellow in Neurosurgery, Sheffield Teaching Hospitals NHS Foundation Trust SP11 - Commissioning of an Arteriovenous Malformation (AVM) Service at the Bristol GammaKnife Centre Lucy Winch, Principal Clinical Scientist, Head of Dosimetry Development, Bristol Haematology and Oncology Centre
5.15pm	How we would treat: Discussion on the treatment of interesting clinical cases - benign Chair: Dr Rovel Colaco, Consultant Clinical Oncologist, The Christie NHS Foundation Trust Panel: Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery, Ian Paddick, Consultant Physicist, Medical Physics Limited, Dr Sara Meade, Consultant Neuro-Oncologist, University Hospitals Birmingham, and Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust
6.00pm	Business meeting
6.30pm	Close
7.30pm	Meeting Dinner Victoria and Albert Hotel
	Friday 30 January - Day two
8.30am	Registration, refreshments, exhibition and poster viewing
8.55am	Welcome and introduction Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery
9.00am	Session 7: Systemic therapies and patterns of care Chairs: Dr Benjamin Sanderson, Consultant Clinical Oncologist, Lancashire Teaching Hospitals NHS Foundation Trust, and Dr Hamoun Rozati, Consultant Clinical Oncologist, Barts Health NHS Trust Sequencing radiosurgery with systemic therapy in melanoma brain metastases Professor Mark Pinkham, Radiation Oncologist, Princess Alexandra Hospital and Icon Cancer Centre, Australia SP12 - Access to stereotactic radiosurgery centres across the United Kingdom – an investigation of travel time Dr Stephen Robinson, Senior Clinical Oncology Registrar and Medical Doctoral Fellow, Sussex Cancer Centre, University Hospitals Sussex NHS Foundation Trust and University of Sussex SP13 - Radionecrosis in brain tumours: National insights on care provision and access to bevacizumab in the United Kingdom Dr Sarah Kingdon, Clinical Fellow, Tessa Jowell Brain Cancer Mission SP14 - Radiosurgery for Brain Metastases: From Few to Many — The New Normal? Ana Luis, Physicist, Medical Physics Limited
9.55am	Session 8: Pituitary Adenomas Chairs: Dr Sara Meade, Consultant Neuro-Oncologist, University Hospitals Birmingham, and Dr Claire Barker, Consultant Clinical Oncologist, The Christie NHS Foundation Trust Keynote: Endocrine outcomes after surgery Professor Karim Meeran, Professor of Endocrinology, Imperial College Healthcare NHS Trust Keynote: Endocrine outcomes after SRS Professor Jean Régis, Professor of Neurosurgery, Aix Marseille University, France Discussion
10.45am	Refreshments, exhibition and poster viewing
11.15am	Session 9: Sponsored Presentations (II) Chair: Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust Technologies that positively impact clinical outcomes Gerrit Hombrink, Senior Product Manager RT Planning Solutions, Brainlab CyberKnife – Non Coplanar. Non Isocentric. On Target! Ludovic Peyre, Senior Director Marketing EIMEA, Accuray Zap- X Gyroscopic Radiosurgery- No Compromise! David Miles, Director, Europe, ZAP Surgical
11.50am	Session 10: Vestibular Schwannoma Chairs: Dr Paul Sanghera, Consultant Clinical Oncologist, University Hospitals Birmingham, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery Keynote: SRS for vestibular schwannoma: Large tumours, retreatment with SRS, what are our organs at risk? Professor Jean Régis, Professor of Neurosurgery, Aix Marseille University, France Delivering Quality Assurance for the NHS England SRS Commissioning Programme: Outcomes and Lessons Luke Gilling, Medical Physicist, RTTQA
12.30pm	Lunch, exhibition and poster viewing
1.15pm	Session 11: SRS for Functional Disorders Chairs: Ian Paddick, Consultant Physicist, Medical Physics Limited, and John Yianni, Consultant Neurosurgeon, Sheffield Teaching Hospitals NHS Foundation Trust Keynote: SRS for movement disorders Professor Jean Régis, Professor of Neurosurgery, Aix Marseille University, France SP15 - Evaluation of Elements’ MRI distortion correction in radiosurgery planning Dr Abdul Hussein Mroué, Lead SRS Physicist, GenesisCare SP16 - Initial experience of using Cyberknife to deliver prolonged fractionation Mitchell Hickman, Consultant Radiographer, Queen Elizabeth Hospital Birmingham
2.00pm	Session 12: Treatment planning and other topics Chairs: Chris Dean, Lead Stereotactic Radiotherapy Physicist, Barts Health NHS Trust, and Dr Sarah Kingdon, Clinical Fellow, Tessa Jowell Brain Cancer Mission Planning a vestibular schwannoma with Gamma Knife – live demonstration Ian Paddick, Consultant Physicist, Medical Physics Limited How we do it: Planning a vestibular schwannoma with the Cyberknife Dr Paul Sanghera, Consultant Clinical Oncologist, University Hospitals Birmingham, and Timothy Jackson, Principal Clinical Scientist for Cyberknife, University Hospitals Birmingham How we do it: Planning a vestibular schwannoma with a linac Dr Abdul Hussein Mroué, Lead SRS Physicist, GenesisCare Discussion
2.50pm	Session 13: Quality of life and Patient-Reported Outcome Measures in SRS Chairs: Dr Jennifer King, Consultant Clinical Oncologist, The Christie NHS Foundation Trust, and Dr Rachel Lewis, Consultant Clinical Oncologist, Barts Health NHS Trust SP17 - Capturing quality-of-life and experience pre-SRS in patients diagnosed with brain metastases Kerlann Le Calvez, Research Associate, Imperial College Healthcare NHS Trust SP18 - Outcomes for Patients with Frailty Receiving SRS for Brain Metastases Dr Catherine Fell, Junior Oncology Fellow, The Christie NHS Foundation Trust SP19 - Cognitive Decline after Brain Radiosurgery (CoDeB-Rad) at 3 months: Cognitive and Quality of Life (QoL) data Anna Bangiri, Principal SRS Radiotherapy Physicist, PhD Fellow, University of Nottingham, Nottingham University Hospitals NHS Trust SP20 - Hippocampal Dosimetry and Neurocognitive Function in Patients undergoing Stereotactic Radiosurgery Dr Najmus Sahar Iqbal, Consultant Clinical Oncologist, Velindre University NHS Trust
3.30pm	Refreshments, exhibition and poster viewing
3.50pm	What are the challenges and opportunities for equitable SRS access? Insights from the Tessa Jowell Brain Cancer Mission Chair: Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust Dr Nicky Huskens, CEO, Tessa Jowell Brain Cancer Mission
4.10pm	Update on DVLA driving restrictions post SRS Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery
4.30pm	Closing remarks Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery